CN100339124C - Guiyuan oral liquid and its preparing process - Google Patents
Guiyuan oral liquid and its preparing process Download PDFInfo
- Publication number
- CN100339124C CN100339124C CNB2005100024280A CN200510002428A CN100339124C CN 100339124 C CN100339124 C CN 100339124C CN B2005100024280 A CNB2005100024280 A CN B2005100024280A CN 200510002428 A CN200510002428 A CN 200510002428A CN 100339124 C CN100339124 C CN 100339124C
- Authority
- CN
- China
- Prior art keywords
- guiyuan
- oral liquid
- grams
- raw material
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a new Chinese medicine and preparation technology thereof, particularly to Guiyuan oral liquid and preparation technology thereof, and the Guiyuan oral liquid has obvious therapeutic effect on a disease of deficiency of both qi and blood of patients suffering from tumors. A prescription of the present invention comprises 100 to 400 grams of astragalus root, 100 to 300 grams of angelica, 100 to 400 grams of prepared rehmannia root, 50 to 300 grams of Chinese date, 50 to 300 grams of amomum fruit and 10 to 100 grams of antler. The preparation technology comprises the steps that water of which the weight is eight times of the weight of the cleaned raw material of the prescription is added into the raw material, and the raw material is decocted in the water for thirty minutes to four hours; subsequently, the solution of the raw material is filtered, centrifuged, decompressed, concentrated, still placed at room temperature and centrifuged to obtain uniform and stable medicinal liquid; the water is added into the medicinal liquid, and the medicinal liquid is shaken to be uniform and achieve that the content of Chinese medicines is 1 g/ml, and the obtained medicinal liquid is the Guiyuan oral liquid. The Guiyuan oral liquid is used for adjuvant treatment of the patients who suffer from the tumors and receive radiotherapy and chemotherapy and has the function of strengthening body resistance and constitution; the Guiyuan oral liquid can obviously alleviate side effect generated after the radiotherapy and the chemotherapy of the patients suffering from the tumors; besides, the Guiyuan oral liquid has obvious therapeutic effect on patients suffering from anemia.
Description
Technical field
The present invention is a kind of new Chinese medicine and manufacturing process, and particularly a kind of disease to the tumor patient qi-blood deficiency syndrome has the Guiyuan oral liquid and the manufacturing process of obvious curative effects.
Background technology
In the prior art, tumor patient all will carry out radiotherapy or chemotherapy, and the side effect of radiotherapy or chemotherapy is bigger.The present invention is the modern Chinese medicine compound preparation of working out on the basis of tcm clinical practice determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, is used to alleviate the side effect after radiotherapy, the chemotherapy, treatment tumor patient qi-blood deficiency syndrome.Chinese medicine in the prescription all meets " the standard of Chinese pharmacopoeia.
Summary of the invention
The objective of the invention is to invent the Guiyuan oral liquid and the manufacturing process of diseases such as a kind of effectively adjuvant therapy of tumors patient qi-blood deficiency syndrome.
The present invention realizes as follows: the present invention includes prescription and manufacturing process, each composition is to provide by weight in the prescription.
Described Guiyuan oral liquid constitutes by following prescription:
Radix Astragali 100-400, Radix Angelicae Sinensis 100-300, Radix Rehmanniae Preparata 100-400, Fructus Jujubae 50-300, Fructus Amomi 50-300, Cornu Cervi Pantotrichum 10-100.
More than prescription need be converted water and carries out friedly can making Guiyuan oral liquid, and the concrete manufacturing process of described Guiyuan oral liquid is as follows:
The decocting that Radix Astragali 100-400, Radix Angelicae Sinensis 100-300, Radix Rehmanniae Preparata 100-400, Fructus Jujubae 50-300, Fructus Amomi 50-300, the Cornu Cervi Pantotrichum 10-100 that cleans is added 8 times of weight boiled 30 minutes～4 hours, filter centrifugal, concentrating under reduced pressure again, room temperature is static, centrifugal again, get a uniform and stable medicinal liquid, and convert water and shake up, reaching Chinese medicine content is 1g/ml, the medicinal liquid of gained is Guiyuan oral liquid, carries out fill, sterilization and packing at last.
Good effect of the present invention is as follows: described Guiyuan oral liquid carries out auxiliary treatment to tumor patient, the obviously side effect of ameliorate tumor patient after radiotherapy, chemotherapy; Described Guiyuan oral liquid has tangible curative effect to the anemia patient.
The specific embodiment
Described Guiyuan oral liquid is prepared by following raw-material next concrete weight: the Radix Astragali: Radix Angelicae Sinensis: Radix Rehmanniae Preparata: Fructus Jujubae: Fructus Amomi: Cornu Cervi Pantotrichum, weight ratio are 1: 0.8: 1: 0.5: 0.5: 0.2 (unit is gram)
The manufacturing process of described Guiyuan oral liquid is as follows: the Radix Astragali: Radix Angelicae Sinensis: Radix Rehmanniae Preparata: Fructus Jujubae: Fructus Amomi: Cornu Cervi Pantotrichum, weight ratio are 1: 0.8: 1: the decocting that 0.5: 0.5: 0.2 (unit is gram) adds 8 times of weight boiled 60 fens; Filter centrifugal, concentrating under reduced pressure again, room temperature is static, centrifugal again, a uniform and stable medicinal liquid, and convert water and shake up, reaching Chinese medicine content is 1g/ml, gained is Guiyuan oral liquid, carries out fill, sterilization and packing at last.
Claims (1)
1. the oral liquid of an energy adjuvant therapy of tumors patient qi-blood deficiency syndrome is characterized in that: the raw material of described Guiyuan oral liquid is to form by following weight ratio:
Radix Astragali 100-400, Radix Angelicae Sinensis 100-300, Radix Rehmanniae Preparata 100-400, Fructus Jujubae 50-300, Fructus Amomi 50-300, Cornu Cervi Pantotrichum 10-100, weight ratio is 1: 0.8: 1: 0.5: 0.5: 0.2, the water that above-mentioned raw materials is added 8 times of weight decocted 30 minutes～4 hours together, filtered centrifugal, concentrating under reduced pressure again, room temperature is static, centrifugal again, a uniform and stable medicinal liquid, and convert water and shake up, reaching Chinese medicine content is 1g/ml, and the medicinal liquid of gained is described oral liquid, carries out fill, sterilization and packing at last.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100024280A CN100339124C (en) | 2005-01-21 | 2005-01-21 | Guiyuan oral liquid and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100024280A CN100339124C (en) | 2005-01-21 | 2005-01-21 | Guiyuan oral liquid and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1679667A CN1679667A (en) | 2005-10-12 |
| CN100339124C true CN100339124C (en) | 2007-09-26 |
Family
ID=35066673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100024280A Expired - Fee Related CN100339124C (en) | 2005-01-21 | 2005-01-21 | Guiyuan oral liquid and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100339124C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102362929B (en) * | 2011-11-09 | 2013-08-21 | 梁金星 | Chinese medicinal composition and extract for treating cancer ischemia, and preparation method and formulation of Chinese medicinal extract |
| CN107837354A (en) * | 2017-12-15 | 2018-03-27 | 佛山市米良仓科技有限公司 | A kind of Chinese medicine for the treatment of cancer |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1457848A (en) * | 2003-06-11 | 2003-11-26 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Black-bone chicken white phoenix preparation medicine and its preparing method |
-
2005
- 2005-01-21 CN CNB2005100024280A patent/CN100339124C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1457848A (en) * | 2003-06-11 | 2003-11-26 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Black-bone chicken white phoenix preparation medicine and its preparing method |
Non-Patent Citations (1)
| Title |
|---|
| 当归补血汤免疫调节作用的研究 梁秀宇等，中医药学刊，第6期 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1679667A (en) | 2005-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101422530A (en) | Traditional Chinese medicine for treating upper right front-tooth pyretic toothache | |
| CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
| CN101204559A (en) | Medicaments composite for coronary heart disease, angina and epigastralgia and preparation method thereof | |
| CN100339124C (en) | Guiyuan oral liquid and its preparing process | |
| CN103055198A (en) | Medicine for treating diabetes mellitus and preparation method thereof | |
| CN103656403A (en) | Traditional Chinese medicine composition for treating phthisis and preparation method of traditional Chinese medicine composition | |
| CN1121867C (en) | Medicine for preventing and treating abortion | |
| CN102018885A (en) | Chinese medicinal preparation for increasing immunity of organism | |
| CN1279944C (en) | Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation | |
| CN101264164A (en) | Medicinal composition for treating tumor and preparation thereof | |
| CN1259090C (en) | Oral liquid for treating common cold and coughing | |
| CN101972374A (en) | Traditional Chinese medicine for treating diabetic gastroplegia | |
| CN101564505A (en) | Chinese medicament for treating pulmonary heart disease | |
| CN1836710A (en) | Granula for cerebrovascular disease and its production method | |
| CN102846810A (en) | Chinese medicinal preparation for treating threatened abortion | |
| CN101897907A (en) | Chinese medicinal preparation for treating night sweat | |
| CN1184993C (en) | Medicines for treating psoriasis | |
| CN1189207C (en) | Chinese medicinal composition for improving human immunity and its preparation method | |
| CN101554434B (en) | Traditional Chinese medicine for treating clinical hypertension | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN111035727A (en) | A Chinese medicinal composition and its preparation method | |
| CN102048873A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102188599A (en) | Medicament for treating cough and preparation method thereof | |
| CN101537068A (en) | Chinese medicine for treating angina | |
| CN101129616A (en) | Traditional Chinese medicine for treating rheumatic heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070926 Termination date: 20150121 |
|
| EXPY | Termination of patent right or utility model |